Based on a positive pre-IND meeting with the U.S. Food and Drug Administration (FDA), Ceruvia Lifesciences has submitted an Investigation New Drug (IND) application to begin a Phase 2 clinical
/PRNewswire/ Ceruvia Lifesciences, a leading neurotransformational medicine biopharmaceutical company today announced the submission of an IND application.
Methylenedioxymethamphetamine (MDMA)-assisted therapy has been able to aid people with severe post-traumatic stress disorder (PTSD), according to researchers.